Mirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosedActivity from announced rounds
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases